Trials / Completed
CompletedNCT04745364
Mindful Kala: Virtual Bharatanatyam Wellness Program for Students
Mindful Kala: Investigating the Psychosocial Effects of a 4-Week Virtual Bharatanatyam Intervention for Students
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In the current study, the researchers propose to develop and pilot test a Bharatanatyam (i.e. Indian classical dance) program called Mindful Kala with the hopes of decreasing stress and increasing psychosocial well-being, mindfulness, cultural competence, and connectedness amongst a group of college students. The investigators hope that this program can help students cultivate well-being during the challenging and stressful time of COVID-19.
Detailed description
Objectives: 1. Evaluate the effects of the Mindful Kala program on outcomes of health-related measures such as mindfulness, stress, connectedness, and wellbeing amongst students. The investigators hypothesize that participants will experience fewer symptoms of stress, increased mindfulness, increased well-being, and increased connectedness. 2. Evaluate the effects of the Mindful Kala program on changes in measures of cultural competence. The investigators hypothesize that the level of cultural competence will increase among the students. 3. Develop and examine the feasibility and acceptability of a 4-week Mindful Kala program for college students.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | A 4-week Bharatanatyam course from the organization Mindful Kala | The 4-week Mindful Kala program focuses on three components of Bharatanatyam: nritta (i.e. technical movements), natya (i.e. storytelling), and nritya (i.e. a combination of movements and narration; nritta + natya). |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2021-04-12
- Completion
- 2021-04-12
- First posted
- 2021-02-09
- Last updated
- 2021-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04745364. Inclusion in this directory is not an endorsement.